Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P4HA1 | P13674 | 3/20 | 0.61 |
| ▸ | P4HTM | Q9NXG6 | 2/20 | 0.61 |
| ▸ | MIF | P14174 | 1/20 | 0.59 |
| ▸ | GABRP | O00591 | 1/20 | 0.57 |
| ▸ | GABRD | O14764 | 1/20 | 0.57 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.57 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.57 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.57 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.57 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.57 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.57 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.57 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.57 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.57 |
| ▸ | GABRE | P78334 | 1/20 | 0.57 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.57 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.57 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.57 |
| ▸ | GABRQ | Q9UN88 | 1/20 | 0.57 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29751460 | 1.00 | P4HA1 (0.61) | P4HA1P4HTMMIFGABRPGABRD | |
| Hydrochloric Acid SCHEMBL1871783 | 0.98 | P4HA1 (0.59) | P4HA1P4HTMMIFGABRPGABRD | |
| Nitrous Acid SCHEMBL27425985 | 0.92 | P4HA1 (0.53) | P4HA1P4HTMMIFGABRPGABRD | |
| SCHEMBL9035328 | 0.92 | ALDH1A1 (0.55) | P4HA1P4HTMMIFGABRPGABRD | |
| SCHEMBL5973043 | 0.84 | RXFP1 (0.44) | P4HA1P4HTMMIFGABRPGABRD | |
| SCHEMBL3500140 | 0.83 | HCAR3 (0.69) | HCAR3 | |
| SCHEMBL2655448 | 0.83 | CPT1B (0.45) | P4HA1P4HTMMIFGABRPGABRD | |
| SCHEMBL31078250 | 0.83 | CPT1B (0.45) | P4HA1P4HTMMIFGABRPGABRD | |
| SCHEMBL7312742 | 0.82 | P4HA1 (0.40) | P4HA1P4HTMMIFGABRPGABRD | |
| SCHEMBL15773930 | 0.80 | NAPRT (0.41) | P4HA1P4HTMMIFGABRPGABRD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 895 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119431432-A | Andrographolide diester derivative, preparation method and application | 西北农林科技大学 | 2025-02-14 | — | — | CN | claimed |
| CN-115433122-B | Preparation method of 6-fluoro nicotinic acid | 大连双硼医药化工有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-116987064-B | Preparation method and application of pyrimidine bisnicotinamide derivative | 宁夏佰斯特医药化工有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-116987064-A | Preparation method and application of pyrimidine bisnicotinamide derivative | 宁夏佰斯特医药化工有限公司 | 2023-11-03 | — | — | CN | claimed |
| CN-115433122-A | Preparation method of 6-fluoronicotinic acid | 大连双硼医药化工有限公司 | 2022-12-06 | — | — | CN | claimed |
| EP-4053117-A1 | ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS | Achillion Pharmaceuticals, Inc. (US) | 2022-09-07 | — | — | EP | claimed |
| WO-2022078279-A1 | ANTIBODY-DRUG CONJUGATE AND USE THEREOF | 昆山新蕴达生物科技有限公司 | 2022-04-21 | — | — | WO | claimed |
| CN-113046734-A | Bivalent palladium complex solution and preparation method and application thereof | 上海天承化学有限公司 | 2021-06-29 | — | — | CN | claimed |
| CN-110317204-A | Pyrazolopyrimidinonefor derivative and its preparation method and application | 安徽农业大学 | 2019-10-11 | — | — | CN | claimed |
| CN-108727295-A | A kind of 2- (3- aminophenyls)-benzothiazole derivant and its preparation method and application | 济南大学 | 2018-11-02 | — | — | CN | claimed |
| JP-9176122-A | — | — | None | — | — | JP | disclosed |
| EP-4741392-A1 | 1H-PYRAZOLO[4,3-C]PYRIDINE COMPOUND, AND COMPOSITION THEREOF AND USE THEREOF | Shenzhen TargetRx Co., Ltd. (CN) | 2026-05-13 | — | — | EP | disclosed |
| CN-116323601-B | 2- (3-Pyridin-2-yl-4-quinolin-4-yl-pyrazol-1-yl) -acetamide derivatives as transforming growth factor-beta receptor I/ALK5 inhibitors | 阿戈麦布西班牙股份有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-12612368-B2 | Cancer treatments targeting cancer stem cells | REMEDY PLAN, INC. (US) | 2026-04-28 | — | — | US | disclosed |
| EP-4720060-A1 | PRMT5 INHIBITORS | Ryvu Therapeutics S.A. (PL) | 2026-04-08 | — | — | EP | disclosed |
| WO-1993006118-A1 | ANTIBACTERIAL, ANTIMYCOPLASMAL COMPOUNDS RELATED TO MUPIROCIN | SMITHKLINE BEECHAM PLC (GB) | 1993-04-01 | — | — | WO | disclosed |
| EP-0244728-B1 | USE OF HETEROARYLETHYL AMINES TO STIMULATE ANIMAL GROWTH, HETEROARYLETHYL AMINES AND PROCESS FOR THEIR PREPARATION | BAYER AG (DE) | 1992-11-11 | — | — | EP | disclosed |
| EP-0506729-A1 | PHARMACEUTICALLY ACTIVE OXAZOLE COMPOUNDS | Beecham Group p.l.c. (GB) | 1992-10-07 | — | — | EP | disclosed |
| WO-1991009856-A1 | PHARMACEUTICALLY ACTIVE OXAZOLE COMPOUNDS | BEECHAM GROUP PLC (GB) | 1991-07-11 | — | — | WO | disclosed |
| US-4112102-A | Halopyridyl derivatives of m-aminotetramisole as anthelmintics | PFIZER INC. (US) | 1978-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12612368-B2 | Cancer treatments targeting cancer stem cells | MALT1, BCOR, MCL1 | P4HA1 310/4885P4HTM 1194/4885MIF 3233/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.